Renvela contains Sevelamer that binds to phosphates and helps reduce high levels of phosphate in the blood, especially in the case of chronic kidney disease.
Renvela is used in the treatment of hyperphosphatemia for adults and children older than 6 years, who suffer from end-stage renal disease and perform dialysis.
The appropriate dose of Renvela is determined by the doctor.
The usual dose is one tablet 3 times a day with meals.
Renvela is not used in case of:
Allergy to drug ingredients.
Bowel obstruction.
Perforation of the digestive tract.
Ulcerative colitis.
Gastrointestinal bleeding.
Hypophosphatemia.
Renvela 800 is not used for pregnant women unless the benefits are higher than the risks, under the supervision of a doctor.
There are not enough studies on the impact of Renvela 800 during the breastfeeding period, so the doctor should be consulted before using it.
Nausea and vomiting.
Diarrhea.
Constipation.
Nasopharyngitis.
Joint pain.
headache.
The doctor should be consulted before taking Renvela along with any other medication, especially:
Ciprofloxacin.
Cyclosporin.
Levothyroxine.